Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Urine Mescaline Screening With a Biochip Array Immunoassay and Quantification by Gas Chromatography-Mass Spectrometry.

Battal D, Barnes AJ, Castaneto MS, Martin TM, Klette KL, Huestis MA.

Ther Drug Monit. 2015 Dec;37(6):805-11. doi: 10.1097/FTD.0000000000000220.

PMID:
25992796
2.

Biochip array technology immunoassay performance and quantitative confirmation of designer piperazines for urine workplace drug testing.

Castaneto MS, Barnes AJ, Concheiro M, Klette KL, Martin TA, Huestis MA.

Anal Bioanal Chem. 2015 Jun;407(16):4639-48. doi: 10.1007/s00216-015-8660-z. Epub 2015 Apr 23.

PMID:
25903022
3.

Method validation of the biochip array technology for synthetic cannabinoids detection in urine.

Castaneto MS, Desrosiers NA, Ellefsen K, Anizan S, Martin TM, Klette KL, Huestis MA.

Bioanalysis. 2014;6(21):2919-30. doi: 10.4155/bio.14.150.

PMID:
25486237
4.

Use and abuse of prescribed opioids, central nervous system depressants, and stimulants among U.S. active duty military personnel in FY 2010.

Jeffery DD, May L, Luckey B, Balison BM, Klette KL.

Mil Med. 2014 Oct;179(10):1141-8. doi: 10.7205/MILMED-D-14-00002.

PMID:
25269133
5.

Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens.

Wohlfarth A, Scheidweiler KB, Castaneto M, Gandhi AS, Desrosiers NA, Klette KL, Martin TM, Huestis MA.

Clin Chem Lab Med. 2015 Feb;53(3):423-34. doi: 10.1515/cclm-2014-0612.

PMID:
25263309
6.

Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens.

Castaneto MS, Scheidweiler KB, Gandhi A, Wohlfarth A, Klette KL, Martin TM, Huestis MA.

Drug Test Anal. 2015 Jun;7(6):483-93. doi: 10.1002/dta.1709. Epub 2014 Sep 17.

7.

Performance characteristics of an ELISA screening assay for urinary synthetic cannabinoids.

Spinelli E, Barnes AJ, Young S, Castaneto MS, Martin TM, Klette KL, Huestis MA.

Drug Test Anal. 2015 Jun;7(6):467-74. doi: 10.1002/dta.1702. Epub 2014 Aug 29.

PMID:
25167963
8.

Evaluation of a homogenous enzyme immunoassay for the detection of synthetic cannabinoids in urine.

Barnes AJ, Young S, Spinelli E, Martin TM, Klette KL, Huestis MA.

Forensic Sci Int. 2014 Aug;241:27-34. doi: 10.1016/j.forsciint.2014.04.020. Epub 2014 Apr 24.

9.

Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology.

Ellefsen KN, Anizan S, Castaneto MS, Desrosiers NA, Martin TM, Klette KL, Huestis MA.

Drug Test Anal. 2014 Jul-Aug;6(7-8):728-38. doi: 10.1002/dta.1633. Epub 2014 Mar 21.

10.
13.

Stabilization of urinary THC solutions with a simple non-ionic surfactant.

Welsh ER, Snyder JJ, Klette KL.

J Anal Toxicol. 2009 Jan-Feb;33(1):51-5.

PMID:
19161669
15.

Rapid quantification of urinary oxycodone and oxymorphone using fast gas chromatography-mass spectrometry.

McKinley S, Snyder JJ, Welsh E, Kazarian CM, Jamerson MH, Klette KL.

J Anal Toxicol. 2007 Oct;31(8):434-41.

PMID:
17988456
16.

Rapid analysis of benzoylecgonine in urine by fast gas chromatography-mass spectrometry.

Romberg RW, Jamerson MH, Klette KL.

J Anal Toxicol. 2006 Oct;30(8):554-8.

PMID:
17132251
17.

Occupational exposure to methamphetamine in workers preparing training AIDS for drug detection dogs.

Stout PR, Horn CK, Klette KL, Given J.

J Anal Toxicol. 2006 Oct;30(8):551-3.

PMID:
17132250
20.

Rapid quantification of urinary 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid using fast gas chromatography-mass spectrometry.

Jamerson MH, Welton RM, Morris-Kukoski CL, Klette KL.

J Anal Toxicol. 2005 Oct;29(7):664-8.

PMID:
16419397
21.
22.
23.
24.

Urinary pharmacokinetics of 11-nor-9-carboxy-delta9-tetrahydrocannabinol after controlled oral delta9-tetrahydrocannabinol administration.

Gustafson RA, Kim I, Stout PR, Klette KL, George MP, Moolchan ET, Levine B, Huestis MA.

J Anal Toxicol. 2004 Apr;28(3):160-7.

PMID:
15107145
26.
27.

Occupational cocaine exposure of crime laboratory personnel preparing training aids for a military working dog program.

Gehlhausen JM, Klette KL, Stout PR, Given J.

J Anal Toxicol. 2003 Oct;27(7):453-8.

PMID:
14606999
29.

Urinary cannabinoid detection times after controlled oral administration of delta9-tetrahydrocannabinol to humans.

Gustafson RA, Levine B, Stout PR, Klette KL, George MP, Moolchan ET, Huestis MA.

Clin Chem. 2003 Jul;49(7):1114-24.

30.

Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples.

Wiegand RF, Klette KL, Stout PR, Gehlhausen JM.

J Anal Toxicol. 2002 Oct;26(7):519-23.

PMID:
12423010
31.
34.

Urine analysis of laboratory personnel preparing cocaine training aids for a military working dog program.

Gehlhausen JM, Klette KL, Given J.

J Anal Toxicol. 2001 Oct;25(7):637-40. No abstract available.

PMID:
11599615
35.
36.

Metabolism of lysergic acid diethylamide (LSD) to 2-oxo-3-hydroxy LSD (O-H-LSD) in human liver microsomes and cryopreserved human hepatocytes.

Klette KL, Anderson CJ, Poch GK, Nimrod AC, ElSohly MA.

J Anal Toxicol. 2000 Oct;24(7):550-6.

PMID:
11043658
39.

Detection of metabolites of lysergic acid diethylamide (LSD) in human urine specimens: 2-oxo-3-hydroxy-LSD, a prevalent metabolite of LSD.

Poch GK, Klette KL, Hallare DA, Manglicmot MG, Czarny RJ, McWhorter LK, Anderson CJ.

J Chromatogr B Biomed Sci Appl. 1999 Mar 5;724(1):23-33.

PMID:
10202954
40.

Neuroprotective sigma ligands attenuate NMDA and trans-ACPD-induced calcium signaling in rat primary neurons.

Klette KL, Lin Y, Clapp LE, DeCoster MA, Moreton JE, Tortella FC.

Brain Res. 1997 May 9;756(1-2):231-40.

PMID:
9187337
41.

Antihistamine concentrations in postmortem blood and liver specimens.

Levine B, Klette K, Radentz S, Smith ML, Smialek JE.

Forensic Sci Int. 1996 Jul 31;81(1):73-6. No abstract available.

PMID:
8784996
42.

Role of calcium in sigma-mediated neuroprotection in rat primary cortical neurons.

Klette KL, DeCoster MA, Moreton JE, Tortella FC.

Brain Res. 1995 Dec 15;704(1):31-41.

PMID:
8750959
43.

Dextromethorphan analogs are neuroprotective in vitro and block glutamate-induced excitotoxic calcium signals in neurons.

Tortella FC, Klette KL, DeCoster MA, Davis BJ, Newman AH.

Neurosci Lett. 1995 Sep 29;198(2):79-82.

PMID:
8592646
44.

Phospholipase A2-induced neurotoxicity in vitro and in vivo in rats.

Clapp LE, Klette KL, DeCoster MA, Bernton E, Petras JM, Dave JR, Laskosky MS, Smallridge RC, Tortella FC.

Brain Res. 1995 Sep 25;693(1-2):101-11.

PMID:
8653397
45.

Sigma receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures.

DeCoster MA, Klette KL, Knight ES, Tortella FC.

Brain Res. 1995 Feb 6;671(1):45-53.

PMID:
7728532
46.

An intoxication involving BRON and verapamil.

Levine B, Jones R, Klette K, Smith ML, Kilbane E.

J Anal Toxicol. 1993 Oct;17(6):381-3.

PMID:
8271787
47.

Cholinesterase activity in postmortem blood as a screening test for organophosphate/chemical weapon exposure.

Klette KL, Levine B, Dreka C, Smith ML, Goldberger BA.

J Forensic Sci. 1993 Jul;38(4):950-5.

PMID:
8355009
48.

Trimethobenzamide cross-reacts in immunoassays of amphetamine/methamphetamine.

Jones R, Klette K, Kuhlman JJ, Levine B, Smith ML, Watson CV, Selavka CM.

Clin Chem. 1993 Apr;39(4):699-700. No abstract available.

49.

Measurement of azacyclonol in urine and serum of humans following terfenadine (Seldane) administration using gas chromatography-mass spectrometry.

Kuhlman JJ Jr, Levine B, Klette KL, Magluilo J Jr, Kalasinsky KS, Smith ML.

J Chromatogr. 1992 Jul 24;578(2):207-13.

PMID:
1400799
50.

Toxicological findings in military aircraft fatalities from 1986-1990.

Klette K, Levine B, Springate C, Smith ML.

Forensic Sci Int. 1992 Mar;53(2):143-8.

PMID:
1592324

Supplemental Content

Loading ...
Support Center